Rune Labs, a San Francisco-based brain data startup, closed a $22.8 million Series A funding round led by Eclipse Ventures. Additional investors in the round include DigiTx Partners and Moment Ventures.
With the fresh fund, Rune Labs hopes to expand its reach and form new partnerships, this financing will enable Rune Labs to expand the number of patients, clinicians, and researchers using our platform to inform precision therapy development and delivery for patients with Parkinson's disease, multiple sclerosis, and depression.
Company: Rune Labs, Inc.
Round: Series A
Funding Month: September 2021
Lead Investors: Eclipse Ventures
Additional Investors: DigiTx Partners and Moment Ventures
Company Website: https://runelabs.io/
Software Category: Brain software and data platform.
About the Company: Rune Labs, is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developers the performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials. Founded in 2018 to accelerate the development of medicines for neurodegenerative and psychiatric disorders.